Overview of the year 2023 at Pharmacogenomics

References

• 1. Devanathan R, Alladi CG, Ravichandran M, Ramasamy K, Uppugunduri CR. Impact of pharmacogenomics in achieving personalized/precision medicine in the clinical setting: a symposium report. Pharmacogenomics 24(3), 123–129 (2023).
  CASGoogle Scholar
• 2. Bollinger A, Jeiziner C, Meyer zu Schwabedissen HE et al. Severe systemic adverse reactions to ophthalmic timolol in a CYP2D6 homozygous *4 allele carrier: a case report. Pharmacogenomics 24(14), 739–746 (2023).
  CASGoogle Scholar
• 3. Wang F, Li W, Wang X, Luo X, Dai P. A single-tube multiplex real-time PCR for HLA-B*38:02 genotype by detecting highly specific SNPs. Pharmacogenomics 24(1), 5–14 (2023).
  CASGoogle Scholar
• 4. Alrajeh K, Roman YM. The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics 24(1), 15–26 (2023).
  CASGoogle Scholar
• 5. Cramer EY, Bartlet J, Chan ER et al. Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism. Pharmacogenomics 24(11), 583–597 (2023).
  CASGoogle Scholar
• 6. AlAzzeh O, Roman YM. The frequency of rs2231142 in ABCG2 among Native Hawaiian and Pacific Islander subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics 24(3), 173–182 (2023).
  CASGoogle Scholar
• 7. Behr MP, Gammal RS, Matthews ML, Wang VC. Healthcare professionals' knowledge, confidence and perceptions of pharmacogenomics in primary care and pain management. Pharmacogenomics 24(7), 371–379 (2023).
  CASGoogle Scholar
• 8. Mapira NL, Thelingwani RS, Chikwambi Z, Kuona P, Masimirembwa C. Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease. Pharmacogenomics 24(7), 359–369 (2023).
  CASGoogle Scholar
• 9. Cacabelos R, Carril JC, Corzo L et al. Pharmacogenetics of anxiety and depression in Alzheimer's disease. Pharmacogenomics 24(1), 27–57 (2023).
  CASGoogle Scholar
• 10. Alsultan A, Alalwan AA, Alshehri B. Interethnic differences in drug response: projected impact of genetic variations in the Saudi population. Pharmacogenomics 24(12), 685–696 (2023).
  CASGoogle Scholar